• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Techniques and Technology to Fight Laboratory Inflation

Techniques and Technology to Fight Laboratory Inflation

by G2 Intelligence Staff | May 18, 2023 | OLP, Webinars, webinars free

This presentation will highlight some of the management techniques and newer technologies for labs to consider when battling rising expenses.

Digital Health Fundraising Falls in 2022 but May Not Have Bottomed Out

by Glenn S. Demby | Jan 31, 2023 | Essential, Funding-lir, Laboratory Industry Report

According to a new report, tough macro-economic conditions caused digital health fundraising levels to fall off dramatically in 2022.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Digital Health Startup Fundraising Remains Robust Despite H1 2022 Declines

Digital Health Startup Fundraising Remains Robust Despite H1 2022 Declines

by Glenn S. Demby | Oct 31, 2022 | Essential, Funding-lir, Laboratory Industry Report

According to a recent report, digital health companies are on track to rake in $21 billion for 2022, below the 2021 total of $29.1 billion.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Investment to Advance Test for Diagnosing Early Alzheimer’s Disease

Investment to Advance Test for Diagnosing Early Alzheimer’s Disease

by SYNAPS Dx | Mar 2, 2022 | Articles, News, Open Content

ROCKVILLE, MD — The announcement of a recent investment from Semler Scientific (SMLR) in SYNAPS Dx (SDx), a privately held company focused on the research, development, and commercialization of diagnostics for neurodegenerative disorders and conditions, including...
Silicon Valley Becomes Epicenter of Lab Investment Scams

Silicon Valley Becomes Epicenter of Lab Investment Scams

by Glenn S. Demby | May 1, 2021 | Blog, News, Open Content

On paper, the Silicon Valley venture capital and innovation that have lifted so many other industries seem like the perfect elixir for medical labs. Perhaps one day it will prove to be just that. But so far at least, things haven’t gone well. Instead of driving...
« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com